• Skip to main content

DistilNFO Health

Health Sector News from India

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

US Charges 3 Indian-Origin Healthcare Startup Ex-Executives in $1-bn Fraud

Share:

November 28, 2019

Three Indian-origin ex-executives of a Chicago-based health tech start-up have been charged by the federal authorities for their alleged roles in a fraud scheme which involved falsifying the company’s financial performance to raise nearly $1 billion in debt and private equity.

The co-founders of Outcome Health Rishi Shah, 33, and Shradha Aggarwal, 34, and former executive Ashik Desai, 26, are among six people accused of fraud “that targeted the company’s clients, lenders and investors,” the US Department of Justice said on Monday.

“Outcome’s former executives and employees allegedly deceived lenders, investors, and their own auditors by falsely representing revenue for additional profit,” said Principal Deputy Assistant Attorney General John P Cronan of the Justice Department’s Criminal Division.

“The charges announced today demonstrate that lies and deception cannot serve as the basis for any company, including start-up companies, to falsely grow revenue for additional capital and private gain,” Cronan said.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Shah and Agarwal co-founded the health care advertising company and owned it in 2015 and 2016, when the alleged fraud occurred.

According to the Justice Department, from 2011 to 2017, the former executives and employees of Outcome sold tens of millions of dollars of advertising inventory that did not exist.

This allegedly resulted in inflated financial statements that the former executives used to raise nearly $ 1 billion in debt and equity financing in 2016 and 2017, it said in a statement.

“The deception alleged to have been committed by the defendants tricked clients into paying for advertising it failed to deliver and served to falsely inflate the value of Outcome Health,” said Assistant US Attorney Brian Hayes, Chief of the Criminal Division for the Northern District of Illinois.

“These charges demonstrate that the FBI and its partners will hold businesses accountable for their misconduct,” said Deputy Special Agent in Charge Larry L Lapp of the FBI’s Chicago Field Office.

The defendants were charged with allegedly over-inflating the company’s revenue figures in order to fraudulently obtain loans from banks, said Inspector General Jay N Lerner of the Federal Deposit Insurance Corporation’s Office of Inspector General (FDIC-OIG).

Shah, Agarwal and Purdy are each charged with various counts of mail fraud, wire fraud and bank fraud. Purdy is also charged with one count of false statements to a financial institution, and Shah is also charged with two counts of transactions in criminal proceeds. Desai is charged with one count of wire fraud, the statement said.

Source: Business Standard

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

Related Posts

  • Experts from India, Japan Discuss Ways to Strengthen Collaboration for Healthcare for Elders
  • Coronavirus Contact-tracing Apps Mean Spying, End to Data PrivacyCoronavirus Contact-tracing Apps Mean Spying, End to Data Privacy
  • Post COVID19: Health and Technology Opportunity for IndiaPost COVID19: Health and Technology Opportunity for India
  • Government Bans Export of 26 Pharma IngredientsGovernment Bans Export of 26 Pharma Ingredients
  • Health Security Must be on the Policy High TableHealth Security Must be on the Policy High Table
  • IISc Experts to Collect Sound Samples of Covid Patients’ Cough, BreathIISc Experts to Collect Sound Samples of Covid Patients’ Cough, Breath
  • Cadila Healthcare Board Approves Transfer of Animal Healthcare Biz to SubsidiaryCadila Healthcare Board Approves Transfer of Animal Healthcare Biz to Subsidiary
  • Cipla Submits Application with USFDA for Generic Version of Asthma DrugCipla Submits Application with USFDA for Generic Version of Asthma Drug

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications